Trial intelligence / Profile preview

Zishen Yutai Pill for IVF-ET in diminished ovarian reserve

ChiCTR1900023042Phase 4Recruiting

Sponsor
Guangdong Women and Children Hospital
Start
May 2019
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in infertility and Diminished Ovarian Reserve (DOR) comparing Zishen Yutai Pill Group with Placebo Group (2 arms). Primary endpoint: High quality embryo number rate. Started May 2019; status: recruiting.

02

Drugs

Zishen Yutai Pill
03

Conditions

infertilityDiminished Ovarian Reserve (DOR)

Beyond the preview

Go deeper on ChiCTR1900023042.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900023042.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call